Topics
insulinProtein
Some identifiable themes for research on con-tinuous subcutaneous insulin infusion (CSII) in the last year are various approaches to fur-ther optimising the control in type 1 diabete
Both Continuous Subcutaneous Insulin Infusion (CSI) and Multiple Daily Injections (MDI) are effectiv...
In both pediatric and adult populations with type 1 diabetes (T1D), technologies such as continuous ...
Continuous subcutaneous insulin infusion (CSII) is used in selected type1 diabetic subjects to achie...
Optimal blood glucose control and the restoration of physiological insulin secretion is an ongoing m...
INTRODUCTION: Continuous subcutaneous insulin infusion (CSII) therapy is currently accepted as a tre...
Introduction: Continuous subcutaneous insulin infusion (CSII) therapy is currently accepted as a tre...
Background and Significance: Diabetes mellitus is a collection of metabolic diseases, characterized ...
Diabetes mellitus (DM) is one of the most common chronic diseases worldwide. According to the Intern...
Intensive insulin treatment and frequent self-monitoring of blood glucose (SMBG) have been recognize...
Technology for diabetes care has undergone major development during recent decades. These technologi...
Continuous subcutaneous insulin infusion (CSII), also known as insulin pump therapy and multiple dos...
Continuous subcutaneous insulin infusion (CSII) for type 2 diabetes mellitus (T2DM) is a promising t...
Type 1 diabetes mellitus (T1DM) represents 5-10% of diabetes cases worldwide. The incidence of T1DM ...
Technologies for diabetes management, such as continuous subcutaneous insulin infusion (CSII) and co...
Technological inventions are being used recently to enable the treatment of diabetes mellitus more e...
Both Continuous Subcutaneous Insulin Infusion (CSI) and Multiple Daily Injections (MDI) are effectiv...
In both pediatric and adult populations with type 1 diabetes (T1D), technologies such as continuous ...
Continuous subcutaneous insulin infusion (CSII) is used in selected type1 diabetic subjects to achie...
Optimal blood glucose control and the restoration of physiological insulin secretion is an ongoing m...
INTRODUCTION: Continuous subcutaneous insulin infusion (CSII) therapy is currently accepted as a tre...
Introduction: Continuous subcutaneous insulin infusion (CSII) therapy is currently accepted as a tre...
Background and Significance: Diabetes mellitus is a collection of metabolic diseases, characterized ...
Diabetes mellitus (DM) is one of the most common chronic diseases worldwide. According to the Intern...
Intensive insulin treatment and frequent self-monitoring of blood glucose (SMBG) have been recognize...
Technology for diabetes care has undergone major development during recent decades. These technologi...
Continuous subcutaneous insulin infusion (CSII), also known as insulin pump therapy and multiple dos...
Continuous subcutaneous insulin infusion (CSII) for type 2 diabetes mellitus (T2DM) is a promising t...
Type 1 diabetes mellitus (T1DM) represents 5-10% of diabetes cases worldwide. The incidence of T1DM ...
Technologies for diabetes management, such as continuous subcutaneous insulin infusion (CSII) and co...
Technological inventions are being used recently to enable the treatment of diabetes mellitus more e...
Both Continuous Subcutaneous Insulin Infusion (CSI) and Multiple Daily Injections (MDI) are effectiv...
In both pediatric and adult populations with type 1 diabetes (T1D), technologies such as continuous ...
Continuous subcutaneous insulin infusion (CSII) is used in selected type1 diabetic subjects to achie...
Add to ORKG